Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mouse DCIR/CLEC4A Antibody, R&D Systems™

Rat Monoclonal Antibody
Supplier: R&D Systems MAB2617SP
This item is not returnable.
View return policy
Description
DCIR/CLEC4A Monoclonal specifically detects DCIR/CLEC4A in Mouse samples. It is validated for Western Blot.Specifications
DCIR/CLEC4A | |
Monoclonal | |
LYOPH | |
Western Blot 1 ug/mL | |
Q9QZ15 | |
Clec4a2 | |
Mouse myeloma cell line NS0-derived recombinant mouse DCIR/CLEC4A isoform 1 Gln70-Leu238 Accession # Q9QZ15 | |
25 μg | |
Primary | |
Detects mouse DCIR/CLEC4A in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) DCIR or recombinant mouse DCAR is observed. | |
Mouse | |
Purified |
Western Blot | |
320511 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
CD367, CLEC4A, CLECSF6, CLECSF6C-type lectin superfamily member 6, C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamilymember 6, C-type lectin domain family 4 member A, C-type lectin domain family 4, member A, DCIRLLIR, DDB27, DDB27C-type lectin DDB27, Dendritic cell immunoreceptor, Lectin-like immunoreceptor, LLIR | |
Rat | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
50856 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2a |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction